Search research articles
Contact Us
Filters
Showing results (151-160 of 182) with videos related to
Page
of 19
Sort By:
Journal of Clinical Lipidology
|
September 20, 2014
National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary
Terry A Jacobson, Matthew K Ito, Kevin C Maki, et al.
Journal of Clinical Lipidology
|
April 26, 2015
National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report
Terry A Jacobson, Matthew K Ito, Kevin C Maki, et al.
Circulation
|
March 15, 2017
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association
David S Siscovick, Thomas A Barringer, Amanda M Fretts, et al.
Clinical Cardiology
|
March 16, 2017
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial
Deepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, et al.
Journal of Clinical Lipidology
|
September 10, 2024
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Daniel E Soffer, Nicholas A Marston, Kevin C Maki, et al.
Journal of the American College of Cardiology
|
March 23, 2019
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
Journal of General Internal Medicine
|
February 18, 2016
Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial
Susan P Bell, Jeffrey L Schnipper, Kathryn Goggins, et al.
Circulation. Cardiovascular Quality and Outcomes
|
March 18, 2010
Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study
Jeffrey L Schnipper, Christianne L Roumie, Courtney Cawthon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 25, 2018
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B Newman, David Preiss, Jonathan A Tobert, et al.
Journal of the American Heart Association
|
December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 182) with videos related to
Sort By:
Page
of 19
Journal of Clinical Lipidology
|
September 20, 2014
National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary
Terry A Jacobson, Matthew K Ito, Kevin C Maki, et al.
Journal of Clinical Lipidology
|
April 26, 2015
National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report
Terry A Jacobson, Matthew K Ito, Kevin C Maki, et al.
Circulation
|
March 15, 2017
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association
David S Siscovick, Thomas A Barringer, Amanda M Fretts, et al.
Clinical Cardiology
|
March 16, 2017
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial
Deepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, et al.
Journal of Clinical Lipidology
|
September 10, 2024
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Daniel E Soffer, Nicholas A Marston, Kevin C Maki, et al.
Journal of the American College of Cardiology
|
March 23, 2019
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
Deepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.
Journal of General Internal Medicine
|
February 18, 2016
Effect of Pharmacist Counseling Intervention on Health Care Utilization Following Hospital Discharge: A Randomized Control Trial
Susan P Bell, Jeffrey L Schnipper, Kathryn Goggins, et al.
Circulation. Cardiovascular Quality and Outcomes
|
March 18, 2010
Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study
Jeffrey L Schnipper, Christianne L Roumie, Courtney Cawthon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 25, 2018
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B Newman, David Preiss, Jonathan A Tobert, et al.
Journal of the American Heart Association
|
December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Page
of 19